A study conduced at the Harvard Medical School in Boston suggests that regular aspirin intake may lower the risk of dying from prostate cancer. According to lead researcher Dr. Christopher Allard, urologic oncology fellow at Harvard, it is too early to recommend aspirin as a prevention method for lethal prostate cancer, however due to its cardiovascular effects, "regular aspirin intake after prostate cancer diagnosis decreased the risk of prostate cancer death by almost 40%."
Click here to read more about this study, findings of which were presented at the January 4th meeting of the American Society of Clinical Oncology (ASCO)
No comments:
Post a Comment